Gala, L.; Lawson, M.; Jomova, K.; Zelenicky, L.; Congradyova, A.; Mazur, M.; Valko, M.
EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum. Molecules 2014, 19, 980-991.
https://doi.org/10.3390/molecules19010980
AMA Style
Gala L, Lawson M, Jomova K, Zelenicky L, Congradyova A, Mazur M, Valko M.
EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum. Molecules. 2014; 19(1):980-991.
https://doi.org/10.3390/molecules19010980
Chicago/Turabian Style
Gala, Lukas, Michael Lawson, Klaudia Jomova, Lubomir Zelenicky, Andrea Congradyova, Milan Mazur, and Marian Valko.
2014. "EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum" Molecules 19, no. 1: 980-991.
https://doi.org/10.3390/molecules19010980
APA Style
Gala, L., Lawson, M., Jomova, K., Zelenicky, L., Congradyova, A., Mazur, M., & Valko, M.
(2014). EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum. Molecules, 19(1), 980-991.
https://doi.org/10.3390/molecules19010980
